ENALAPRIL
Clinical Indication
Heart failure and hypertension in infants and children
Comments
In line with SCA: Paediatric Cardiology Medications
Date of classification
December 2013
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.